According to the Zhitong Finance App, Shisi Pharmaceutical Group (02005.HK) announced that the group's laberol hydrochloride has been approved by the China National Drug Administration and registered as an active ingredient for use in marketed formulations. Laberolol hydrochloride is mainly used to treat high blood pressure.

According to the Zhitong Finance App, Shisi Pharmaceutical Group (02005.HK) announced that the group's laberol hydrochloride has been approved by the China National Drug Administration and registered as an active ingredient for use in marketed formulations. Laberolol hydrochloride is mainly used to treat high blood pressure.